Shopping Cart
- Remove All
 
Your shopping cart is currently empty
Complement C5-IN-1 is a small-molecule inhibitor of complement component 5 protein (C5).

| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 1 mg | $93 | In Stock | |
| 5 mg | $191 | In Stock | |
| 10 mg | $277 | In Stock | |
| 25 mg | $428 | In Stock | |
| 50 mg | $569 | In Stock | |
| 100 mg | $773 | In Stock | |
| 200 mg | $987 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $211 | In Stock | 
| Description | Complement C5-IN-1 is a small-molecule inhibitor of complement component 5 protein (C5).  | 
| In vitro | Complement C5-IN-1 (Compound 7) interacts with C5 to prevent its cleavage by the C5 convertase and blocks zymosan-induced the membrane-attack complex (MAC) deposition in 50% human whole blood (IC50: 0.77 µM)[1].  | 
| Molecular Weight | 444.52 | 
| Formula | C24H32N2O6 | 
| Cas No. | 2365402-67-9 | 
| Smiles | COc1ccccc1[C@H](C)NC(=O)Nc1cc(OCCCC(C)C)c(OC)cc1C(O)=O | 
| Relative Density. | 1.179 g/cm3 (Predicted) | 
| Color | White | 
| Appearance | Solid | 
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 90 mg/mL (202.47 mM), Sonication is recommended.   | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (7.42 mM), Sonication is recommended.  Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table  | ||||||||||||||||||||||||||||||||||||
DMSO 
  | ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.